Using mobile technology to understand and manage tuberculosis in Africa
Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program
This study is exploring how mobile technology can help us understand and manage tuberculosis better in Uganda, with the hope that it will lead to better treatment and support for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-10999457 on NIH RePORTER |
What this research studies
This research focuses on leveraging digital mobile technologies to better understand and manage tuberculosis (TB) in sub-Saharan Africa, particularly in Uganda. By utilizing tools such as cellular phone metadata, GPS-enabled devices, and smartphone applications, the project aims to gather valuable data on TB transmission and treatment adherence. The goal is to develop new metrics that can lead to actionable strategies for reducing TB burden and improving patient outcomes. Patients may benefit from improved treatment adherence and management strategies derived from this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in sub-Saharan Africa, particularly those at risk of or currently diagnosed with tuberculosis.
Not a fit: Patients outside of sub-Saharan Africa or those without tuberculosis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective management and treatment of tuberculosis, ultimately reducing its prevalence and mortality rates.
How similar studies have performed: Previous research has shown promise in using mobile technology for health management, indicating that this approach could be effective in addressing tuberculosis.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Sekandi, Juliet Nabbuye — University of Georgia
- Study coordinator: Sekandi, Juliet Nabbuye
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.